“…Tricyclic compound 9 (34 mg, 0.14 mmol, 1 equiv) was subjected to the ring expansion procedure being performed as described before for the preparation of 1b. After purification by chromatography (1:0 → 3:2 hexane/EtOAc), homologated compound 10a was obtained as a colorless oil (11.7 mg, 33%) along with compound 10b (5.4 mg, 15%): IR (NaCl) 2955, 1694, 1456, 1434, 912 cm −1 ; 1 H NMR (400 MHz, CDCl 3 ) δ 6.00− 5.90 (m, 1H, �CH), 5.13 (d, J = 16.8 Hz, 1H, �CH 2 , H-trans), 5.04 (d, J = 10.0 Hz, 1H, �CH 2 , H-cis), 4.08 (dd, J = 13.6, 7.6 Hz, 1H, H-10), 3.63−3.61 (m, 1H, H-8a), 2.69−2.62 (m, 1H, CH 2 -3), 2.50− 2.45 (m, 2H, H-5), 2.43−2.30 (m, 3H, H-10, H-3, and H-7), 2.16− 2.03 (m, 4H, H-8, CH 2 -3, and H-9), 1.71 (ddd, J = 15.5, 8.8, 2.4 Hz, 1H, H-4), 1.48 (ddd, J = 15.5, 9.6, 4.0 Hz, 1H, H-4), 1.17 (s, 3H, Me-3a), 1.08 (d, J = 6.8 Hz, 3H, Me-9); 13 (3RS,3aSR,7RS,8aSR,9RS)-3-Allyl-3a,9-dimethylhexahydro-2H-7,1-ethanocyclohepta [b]pyrrole-2,5(3H)-dione (10b). IR (NaCl) 2957, 1699, 1459, 903 cm −1 ; 1 H NMR (400 MHz, CDCl 3 ) δ 5.98−5.88 (m, 1H, �CH), 5.17 (br d, J = 17 Hz, 1H, �CH 2 , Htrans), 5.02 (br d, J = 10 Hz, 1H, �CH 2 , H-cis), 4.00 (dd, J = 13.6, 8.0 Hz, 1H, H-10), 3.58 (d, J = 8.4 Hz, 1H, H-8a), 2.88−2.80 (m, 1H, CH 2 -3), 2.64 (dd, J = 12.0, 7.2 Hz, 1H, H-6), 2.55−2.50 (m, 1H, CH 2 -3), 2.48 and 2.40 (2d, J = 11.8 Hz, 1H each, H-4), 2.35−2.19 (m, 4H, H-6, H-10, H-3, and H-8), 2.02 (dd, J = 15.4, 2.2 Hz, H-8), 1.95−1.88 (m, 2H, H-7 and H-9), 1.18 (s, 3H, Me-3a), 0.96 (d, J = 6.8 Hz, Me-9); 13 C{ 1 H} NMR (101 MHz, CDCl 3 ) δ 208.1 (C-5), 172.7 (C-2), 137.4 (�CH), 116.0 (�CH 2 ), 61.1 (C-8a), 54.5 (C-6), 52.0 (C-3), 45.9 (C-4), 44.1 (C-3a), 41.1 (C-10), 33.5 (C-9), 32.9 (C-7), 30.3 (CH 2 -3), 25.7 (Me-3a), 22.0 (C-8), 20.0 (Me-9).…”